275 related articles for article (PubMed ID: 18806775)
21. Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia.
Chen Y; Jones KL; Anastassiadis K; Kranz A; Stewart AF; Grembecka J; Meyerson M; Ernst P
Exp Hematol; 2019 Jan; 69():37-42. PubMed ID: 30315824
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
Liu L; Zhang H; Shi L; Zhang W; Yuan J; Chen X; Liu J; Zhang Y; Wang Z
Oncol Rep; 2014 Oct; 32(4):1395-400. PubMed ID: 25109327
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms.
Marchand B; Tremblay I; Cagnol S; Boucher MJ
Carcinogenesis; 2012 Mar; 33(3):529-37. PubMed ID: 22201186
[TBL] [Abstract][Full Text] [Related]
24. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.
Ayton PM; Cleary ML
Genes Dev; 2003 Sep; 17(18):2298-307. PubMed ID: 12952893
[TBL] [Abstract][Full Text] [Related]
25. Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma.
Wu X; Stenson M; Abeykoon J; Nowakowski K; Zhang L; Lawson J; Wellik L; Li Y; Krull J; Wenzl K; Novak AJ; Ansell SM; Bishop GA; Billadeau DD; Peng KW; Giles F; Schmitt DM; Witzig TE
Blood; 2019 Jul; 134(4):363-373. PubMed ID: 31101621
[TBL] [Abstract][Full Text] [Related]
26. The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.
Baker A; Gregory GP; Verbrugge I; Kats L; Hilton JJ; Vidacs E; Lee EM; Lock RB; Zuber J; Shortt J; Johnstone RW
Cancer Res; 2016 Mar; 76(5):1158-69. PubMed ID: 26627013
[TBL] [Abstract][Full Text] [Related]
27. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
[TBL] [Abstract][Full Text] [Related]
28. The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice.
Kong CT; Sham MH; So CW; Cheah KS; Chen SJ; Chan LC
Leukemia; 2006 Oct; 20(10):1829-39. PubMed ID: 16888613
[TBL] [Abstract][Full Text] [Related]
29. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
30. Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway.
G-Amlak M; Uddin S; Mahmud D; Damacela I; Lavelle D; Ahmed M; van Besien K; Wickrema A
Biochem Biophys Res Commun; 2002 Oct; 297(4):760-4. PubMed ID: 12359217
[TBL] [Abstract][Full Text] [Related]
31. Glycogen synthase kinase 3: more than a namesake.
Rayasam GV; Tulasi VK; Sodhi R; Davis JA; Ray A
Br J Pharmacol; 2009 Mar; 156(6):885-98. PubMed ID: 19366350
[TBL] [Abstract][Full Text] [Related]
32. Inhibiting Glycogen Synthase Kinase 3 Reverses Obesity-Induced White Adipose Tissue Inflammation by Regulating Apoptosis Inhibitor of Macrophage/CD5L-Mediated Macrophage Migration.
Wang L; Wang Y; Zhang C; Li J; Meng Y; Dou M; Noguchi CT; Di L
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2103-2116. PubMed ID: 30026270
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic dysregulation of leukaemic HOX code in MLL-rearranged leukaemia mouse model.
Ng RK; Kong CT; So CC; Lui WC; Chan YF; Leung KC; So KC; Tsang HM; Chan LC; Sham MH
J Pathol; 2014 Jan; 232(1):65-74. PubMed ID: 24122813
[TBL] [Abstract][Full Text] [Related]
34. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.
MacAulay K; Hajduch E; Blair AS; Coghlan MP; Smith SA; Hundal HS
Eur J Biochem; 2003 Sep; 270(18):3829-38. PubMed ID: 12950267
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.
Borkin D; He S; Miao H; Kempinska K; Pollock J; Chase J; Purohit T; Malik B; Zhao T; Wang J; Wen B; Zong H; Jones M; Danet-Desnoyers G; Guzman ML; Talpaz M; Bixby DL; Sun D; Hess JL; Muntean AG; Maillard I; Cierpicki T; Grembecka J
Cancer Cell; 2015 Apr; 27(4):589-602. PubMed ID: 25817203
[TBL] [Abstract][Full Text] [Related]
36. MLL translocations, histone modifications and leukaemia stem-cell development.
Krivtsov AV; Armstrong SA
Nat Rev Cancer; 2007 Nov; 7(11):823-33. PubMed ID: 17957188
[TBL] [Abstract][Full Text] [Related]
37. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.
Chen L; Sun Y; Wang J; Jiang H; Muntean AG
Oncotarget; 2016 May; 7(18):25208-23. PubMed ID: 27007052
[TBL] [Abstract][Full Text] [Related]
39. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammary epithelial tumor cells.
Failor KL; Desyatnikov Y; Finger LA; Firestone GL
Mol Endocrinol; 2007 Oct; 21(10):2403-15. PubMed ID: 17595317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
